Adjunctive therapies in severe pneumonia in critical care patients.

Tzovaras, N; Karvouniaris, M; Makris, D; Zakynthinos, E

Tzovaras, N; Karvouniaris, M; Makris, D; Zakynthinos, E.

Affiliation

Tzovaras N; Department of Critical Care Medicine, University Hospital of Larisa, University of Thessaly, Larisa 41000, Greece.

Infect Disord Drug Targets ; 11(4): 395-400, 2011 Aug.

Article in En | MEDLINE | ID: mdl-21679141

Subject(s)

Pneumonia/drug therapy; Sepsis/drug therapy; Shock, Septic/drug therapy; Animals; Community-Acquired Infections/drug therapy; Community-Acquired Infections/physiopathology; Critical Illness; Cross Infection/drug therapy; Cross Infection/physiopathology; Glucocorticoids/therapeutic use; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Inflammation/drug therapy; Inflammation/etiology; Inflammation/physiopathology; Pneumonia/physiopathology; Protein C/therapeutic use; Sepsis/physiopathology; Severity of Illness Index; Shock, Septic/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Shock, Septic / Sepsis Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Infect Disord Drug Targets Journal subject: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Greece Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links